Heterogeneity in the MS prodrome & impact on disease progression (PrOMS-HD). Clinical Research Project Grant Type: Discovery Grant (operating) by Multiple Sclerosis Society of Canada Total Funding – $99,983 (Canadian dollar) Funding Competitive?: Yes Funding Reference Number: (EGID): 903124 Multiple Funding Bodies
Posted May/2022: Ioannidis JPA, Baas J, Klavans R, Boyack KW (2019) A standardized citation metrics author database annotated for scientific field.
The ACTRIMS Forum 2023, San Diego, California, Conference Date: 2023/2 Risk of Multiple Sclerosis in People with HIV: An International Cohort study. Authors: E. Kingwell, A. Manouchehrinia, F. Zhu, K. McKay, J. Li, M. Ye, P. Sereda, J. Trigg, K. Kooij, M. Gisslén, A. Ekström, J. Hillert, R. Hogg, H. Tremlett. Presentation Type: Oral Presentation […]
Written by Sharon Roman, a patient-partner and writer for the British Medical Journal group, Tremlett’s MS Research Explained is dedicated to explaining our work in plain language.
Welcome to the UBC PiMS Group Website
Our research group is physically located within the Djavid Mowafaghian Centre for Brain Health and University of British Columbia’s hospital. We are part of the Department of Medicine and Division of Neurology. If that wasn’t enough, we are also affiliated with the Vancouver Coastal Health Research Institute.
